CSIMarket
 


Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

CDIF's EPS Net Growth by Quarter and Year

Cardiff Lexington's EPS Net results by quarter and year




CDIF EPS Net (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December 0.00 0.00 -0.01 0.01
III Quarter September -0.16 0.00 0.00 0.02
II Quarter June -0.04 0.00 0.00 -0.02
I Quarter March -0.11 0.00 0.00 -0.03
FY   -0.31 0.00 -0.01 -0.02



CDIF EPS Net fourth quarter 2024 Y/Y Growth Comment
Cardiff Lexington Corporation in the fourth quarter 2024 recorded EPS net loss of $ 0.00 .

According to the results reported in the fourth quarter 2024, Cardiff Lexington Corporation achieved the best EPS Net growth in Healthcare Facilities industry. While Cardiff Lexington Corporation' s EPS Net no change of % ranks overall at the positon no. in the fourth quarter 2024.




CDIF EPS Net ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -80 %
III Quarter September - - - -99.34 %
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cardiff Lexington's fourth quarter 2024 EPS Net $ 0.00 CDIF's Income Statement
Cardiff Lexington's fourth quarter 2023 EPS Net $ 0.00 Quarterly CDIF's Income Statement


CDIF EPS Net (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -50 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cardiff Lexington's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q EPS Net Comment
Even if Cardiff Lexington Corporation in the IV. Quarter 2024 showed EPS net loss of $ 0.00 , some analyst said, that current results show slight up side compare to the -0.16 in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential EPS Net growth. While Cardiff Lexington's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q EPS Net Comment
Despite the fact, that Cardiff Lexington Corporation in the IV. Quarter 2024 revealed EPS net loss of $ 0.00 , it should be point out, that those numbers point to improvement in contrast to the -0.16 in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential EPS Net growth. While Cardiff Lexington's EPS Net growth quarter on quarter, overall rank is .


Cardiff Lexington's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
Cumulative EPS Net 12 Months Ending $ -0.31 $ -0.31 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #


Cumulative EPS Net growth Comment
Cardiff Lexington Corporation' has realized cumulative trailing twelve months EPS net loss of $ 0 in the Dec 31 2024 period.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Cardiff Lexington Corporation' has realized cumulative trailing twelve months EPS net loss of $ 0 in the Dec 31 2024 period.

Cardiff Lexington Corporation achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Healthcare Facilities Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
CDIF's EPS Net Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for CDIF's Competitors
EPS Net Growth for Cardiff Lexington's Suppliers
EPS Net Growth for CDIF's Customers

You may also want to know
CDIF's Annual Growth Rates CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2024
Integra Lifesciences Holdings Corp-0.25%$ -0.247 
Inmode Ltd -2.17%$ -2.174 
West Pharmaceutical Services Inc -2.82%$ -2.816 
Merit Medical Systems Inc-3.10%$ -3.100 
Vertex Pharmaceuticals Inc-4.11%$ -4.112 
Hca Healthcare Inc -5.20%$ -5.198 
Progyny Inc -5.25%$ -5.253 
Iqvia Holdings Inc -5.47%$ -5.473 
Align Technology inc -14.86%$ -14.858 
Johnson and Johnson-15.26%$ -15.256 
Corcept Therapeutics Inc-15.51%$ -15.511 
Hologic Inc-15.53%$ -15.534 
Alpha Pro Tech Ltd -16.97%$ -16.969 
Amphastar Pharmaceuticals Inc -17.09%$ -17.093 
Amgen Inc -19.74%$ -19.742 
3m Company-21.53%$ -21.534 
National Research Corporation-22.49%$ -22.490 
Regeneron Pharmaceuticals Inc -22.49%$ -22.491 
Neurocrine Biosciences Inc -29.21%$ -29.210 
Dexcom Inc -35.45%$ -35.450 
Profound Medical Corp -35.55%$ -35.555 
Penumbra Inc -36.31%$ -36.309 
Siga Technologies Inc-38.52%$ -38.525 
Utah Medical Products Inc-39.38%$ -39.381 
Zimmer Biomet Holdings Inc -40.29%$ -40.286 
Collegium Pharmaceutical Inc -42.49%$ -42.487 
Entera Bio Ltd -43.97%$ -43.966 
Acadia Healthcare Company Inc -44.43%$ -44.434 
Healthcare Services Group Inc -47.08%$ -47.075 
Stryker Corp-52.40%$ -52.396 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com